Tag: off-patent medicines
UK faces risk of becoming a ‘backwater’ supply market for medicines, BGMA manifesto warns
The association, which represents the interests of UK-based manufacturers and suppliers of off-patent generic and biosimilar medicines, has set out a range of policy...
Matthew Salzmann elected as new BGMA Vice Chair
He is committed to making the UK a global hub for off-patent medicine innovationÂ
The British Generic Manufacturers Association (BGMA) has elected Matthew Salzmann, UK...
Current VPAS rate is threat to billions of pound of NHS savings; BGMA proposes reform
The British Generic Manufacturers Association (BGMA) has published a positioning paper which sets out the objectives that need to be delivered through the next...